Integra LifeSciences Holdings Corporation (IART) Stock Overview
Explore Integra LifeSciences Holdings Corporation’s financial performance, market position, analyst ratings, and future outlook.
Integra LifeSciences Holdings Corporation (IART)
Key Financials
Key Financials
Market Cap
1.4B
P/E Ratio
-198.36
EPS (TTM)
$2.36
ROE
-0.01%
IART Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Integra LifeSciences Holdings Corporation (NASDAQ: IART) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Integra LifeSciences Holdings Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of IART on the NASDAQ shows an RSI of 52.97, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $12.79 for the NASDAQ listing.
Key metrics behind Integra LifeSciences Holdings Corporation's NASDAQ-traded stock include a P/E ratio of -198.36 and a market capitalization of 1.4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of IART on the NASDAQ.